<i>Candida auris</i> Bloodstream Infections in Russia

<i>Candida auris</i>—a fungus (yeast) that can cause hospital outbreaks was first recognized in 2009. The authors report data on 38 cases of <i>C. auris</i> bloodstream infections in multidisciplinary hospitals situated in two distantly located regions of Russia, considering...

Full description

Bibliographic Details
Main Authors: Natalia E. Barantsevich, Antonina V. Vetokhina, Natalia I. Ayushinova, Olga E. Orlova, Elena P. Barantsevich
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/9/557
_version_ 1797555125371273216
author Natalia E. Barantsevich
Antonina V. Vetokhina
Natalia I. Ayushinova
Olga E. Orlova
Elena P. Barantsevich
author_facet Natalia E. Barantsevich
Antonina V. Vetokhina
Natalia I. Ayushinova
Olga E. Orlova
Elena P. Barantsevich
author_sort Natalia E. Barantsevich
collection DOAJ
description <i>Candida auris</i>—a fungus (yeast) that can cause hospital outbreaks was first recognized in 2009. The authors report data on 38 cases of <i>C. auris</i> bloodstream infections in multidisciplinary hospitals situated in two distantly located regions of Russia, considering predisposing factors, antifungal susceptibility of isolates, treatment, and outcomes. Interhospital transfers of patients and labor migration contributed to the spread of <i>C. auris</i>. The South Asian lineage of the studied strains was indicated by K143R substitution in <i>ERG11</i> gene and phylogenetic analysis of internal transcribed spacer and D1-D2 domain. All isolates from <i>C. auris</i> candidemia cases were susceptible to echinocandins. High-level resistance to fluconazole and resistance to amphotericin B were present in the majority of strains. The overall all-cause mortality rate in <i>C. auris</i> bloodstream infections was 55.3% and the 30-day all-cause mortality rate 39.5%. The attributable mortality was 0%. Eradication of <i>C. auris</i> from blood was associated with the favourable outcomes in patients. It was achieved irrespective of whether antifungal preparations within or outside the susceptibility range were administered. Further international surveillance and studies providing consensus guidelines for the management of <i>C. auris</i> infections are needed.
first_indexed 2024-03-10T16:43:02Z
format Article
id doaj.art-8c73b302c9c14eeebc6f2886920ef449
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T16:43:02Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-8c73b302c9c14eeebc6f2886920ef4492023-11-20T11:52:58ZengMDPI AGAntibiotics2079-63822020-08-019955710.3390/antibiotics9090557<i>Candida auris</i> Bloodstream Infections in RussiaNatalia E. Barantsevich0Antonina V. Vetokhina1Natalia I. Ayushinova2Olga E. Orlova3Elena P. Barantsevich4Almazov National Medical Research Centre, 2 Akkuratova str., 197341 St. Petersburg, RussiaAlmazov National Medical Research Centre, 2 Akkuratova str., 197341 St. Petersburg, RussiaAlmazov National Medical Research Centre, 2 Akkuratova str., 197341 St. Petersburg, RussiaAlmazov National Medical Research Centre, 2 Akkuratova str., 197341 St. Petersburg, RussiaAlmazov National Medical Research Centre, 2 Akkuratova str., 197341 St. Petersburg, Russia<i>Candida auris</i>—a fungus (yeast) that can cause hospital outbreaks was first recognized in 2009. The authors report data on 38 cases of <i>C. auris</i> bloodstream infections in multidisciplinary hospitals situated in two distantly located regions of Russia, considering predisposing factors, antifungal susceptibility of isolates, treatment, and outcomes. Interhospital transfers of patients and labor migration contributed to the spread of <i>C. auris</i>. The South Asian lineage of the studied strains was indicated by K143R substitution in <i>ERG11</i> gene and phylogenetic analysis of internal transcribed spacer and D1-D2 domain. All isolates from <i>C. auris</i> candidemia cases were susceptible to echinocandins. High-level resistance to fluconazole and resistance to amphotericin B were present in the majority of strains. The overall all-cause mortality rate in <i>C. auris</i> bloodstream infections was 55.3% and the 30-day all-cause mortality rate 39.5%. The attributable mortality was 0%. Eradication of <i>C. auris</i> from blood was associated with the favourable outcomes in patients. It was achieved irrespective of whether antifungal preparations within or outside the susceptibility range were administered. Further international surveillance and studies providing consensus guidelines for the management of <i>C. auris</i> infections are needed.https://www.mdpi.com/2079-6382/9/9/557treatmentechinocandinsazolessusceptibilityamphotericin Bmortality
spellingShingle Natalia E. Barantsevich
Antonina V. Vetokhina
Natalia I. Ayushinova
Olga E. Orlova
Elena P. Barantsevich
<i>Candida auris</i> Bloodstream Infections in Russia
Antibiotics
treatment
echinocandins
azoles
susceptibility
amphotericin B
mortality
title <i>Candida auris</i> Bloodstream Infections in Russia
title_full <i>Candida auris</i> Bloodstream Infections in Russia
title_fullStr <i>Candida auris</i> Bloodstream Infections in Russia
title_full_unstemmed <i>Candida auris</i> Bloodstream Infections in Russia
title_short <i>Candida auris</i> Bloodstream Infections in Russia
title_sort i candida auris i bloodstream infections in russia
topic treatment
echinocandins
azoles
susceptibility
amphotericin B
mortality
url https://www.mdpi.com/2079-6382/9/9/557
work_keys_str_mv AT nataliaebarantsevich icandidaaurisibloodstreaminfectionsinrussia
AT antoninavvetokhina icandidaaurisibloodstreaminfectionsinrussia
AT nataliaiayushinova icandidaaurisibloodstreaminfectionsinrussia
AT olgaeorlova icandidaaurisibloodstreaminfectionsinrussia
AT elenapbarantsevich icandidaaurisibloodstreaminfectionsinrussia